New York State Common Retirement Fund’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Buy |
10,616
+7,700
| +264% | +$103K | ﹤0.01% | 2401 |
|
|
2025
Q1 | $30K | Sell |
2,916
-7,400
| -72% | -$76.1K | ﹤0.01% | 2910 |
|
|
2024
Q4 | $163K | Hold |
10,316
| – | – | ﹤0.01% | 2392 |
|
|
2024
Q3 | $599K | Sell |
10,316
-2,300
| -18% | -$134K | ﹤0.01% | 1873 |
|
|
2024
Q2 | $577K | Sell |
12,616
-4,506
| -26% | -$206K | ﹤0.01% | 1984 |
|
|
2024
Q1 | $1.13M | Buy |
17,122
+6,829
| +66% | +$452K | ﹤0.01% | 1716 |
|
|
2023
Q4 | $409K | Sell |
10,293
-44
| -0.4% | -$1.75K | ﹤0.01% | 2174 |
|
|
2023
Q3 | $330K | Buy |
10,337
+92
| +0.9% | +$2.94K | ﹤0.01% | 2216 |
|
|
2023
Q2 | $412K | Buy |
10,245
+178
| +2% | +$7.16K | ﹤0.01% | 2179 |
|
|
2023
Q1 | $430K | Sell |
10,067
-2,985
| -23% | -$128K | ﹤0.01% | 2250 |
|
|
2022
Q4 | $627K | Buy |
13,052
+493
| +4% | +$23.7K | ﹤0.01% | 2207 |
|
|
2022
Q3 | $472K | Buy |
12,559
+1,545
| +14% | +$58.1K | ﹤0.01% | 2350 |
|
|
2022
Q2 | $304K | Sell |
11,014
-23
| -0.2% | -$635 | ﹤0.01% | 2595 |
|
|
2022
Q1 | $600K | Buy |
11,037
+10
| +0.1% | +$544 | ﹤0.01% | 2334 |
|
|
2021
Q4 | $645K | Sell |
11,027
-31
| -0.3% | -$1.81K | ﹤0.01% | 2308 |
|
|
2021
Q3 | $437K | Sell |
11,058
-3,244
| -23% | -$128K | ﹤0.01% | 2536 |
|
|
2021
Q2 | $607K | Buy |
14,302
+2,402
| +20% | +$102K | ﹤0.01% | 2490 |
|
|
2021
Q1 | $732K | Buy |
11,900
+800
| +7% | +$49.2K | ﹤0.01% | 2270 |
|
|
2020
Q4 | $783K | Buy |
11,100
+4,700
| +73% | +$332K | ﹤0.01% | 2148 |
|
|
2020
Q3 | $247K | Hold |
6,400
| – | – | ﹤0.01% | 2552 |
|
|
2020
Q2 | $240K | Buy |
+6,400
| New | +$240K | ﹤0.01% | 2557 |
|